Biotech sell-off continues

by | Oct 23, 2009 | BIOgraph

We commented on Tuesday about the broad selling of all biotech stocks large and small and this trend continues through today. AMGN shares are down this week despite earnings EPS of $1.49 beating estimates of $1.27 as regulatory concerns about its experimental...

Biotech stocks in stealth retreat

Biotech stocks were in a broad retreat today for reasons that are not yet apparent as the Nasdaq and S&P were only down a modest 0.6%. Large caps that were hard hit include AMGN, BIIB,and VRTX as well as the major ETF’s IBB and XBI. My broad index of 35 mid...

Life Science Market Performance Q3 2009

Biotech summer rally sparked by deals Life Science stocks kept pace with market sectors that offer comparable risk and performance: Small cap growth, science and technology and midcap growth. The bellwether, broadly diversified ETF IBB was up 16% moving from 70 to 81...

Markets stable after sell-off;Dollar down

The dollar traded down 0.38% after a fierce rally yesterday that coincided with a weak stock market. Crude fell 1.5% today to $69.77 a barrel with weak employment number and assumption that energy demand will take a long time to rebound. Unemployment rose to a 26 year...

Pin It on Pinterest